相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma
Tomar Ghansah et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Immunotherapeutic benefit of α-interferon (IFNα) in survivin2B-derived peptide vaccination for advanced pancreatic cancer patients
Hidekazu Kameshima et al.
CANCER SCIENCE (2013)
Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99]
P. Albers et al.
ANNALS OF ONCOLOGY (2011)
Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients
Hidekazu Kameshima et al.
CANCER SCIENCE (2011)
Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: A phase II study of the SUOC group
Hiroshi Kitamura et al.
CANCER SCIENCE (2011)
Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines
Arnulf Stenzl et al.
EUROPEAN UROLOGY (2011)
T Cells as Vehicles for Cancer Vaccination
Adham S. Bear et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Recent Developments in Cancer Vaccines
Karolina Palucka et al.
JOURNAL OF IMMUNOLOGY (2011)
Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
Ichiya Honma et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract
Joaquim Bellmunt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting of CD4+CD25high cells while preserving CD4+CD25low cells with low-dose chimeric anti-CD25 antibody in adoptive immunotherapy of cancer
Riki Okita et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
Ji-Yan Liu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: Implications for specific immunotherapy
Hiroshi Kitamura et al.
UROLOGY (2006)
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
L Höltl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
分享论文
